iPLATO awarded £1.7m SBRI contract to drive health equity and improve bowel cancer screening rates
iPLATO, a Huma Company, today announced that it has been awarded a £1.7m research contract by Small Business Research Institute (SBRI) Healthcare, to improve the uptake of bowel cancer screening across South East London. The programme will address health inequalities by focusing on groups known to be less engaged with screening, forming a blueprint for potential national adoption.
